PACS Group (PACS) Financials

$32.06 -1.53 (-4.56%)

Closing price 03:59 PM Eastern

Extended Trading

$36.90 +4.84 (+15.10%)

As of 05:05 PM Eastern

Annual Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	150	113	56	192
Consolidated Net Income / (Loss)	150	113	55	191
Net Income / (Loss) Continuing Operations	150	113	55	191
Total Pre-Tax Income	207	157	102	284
Total Operating Income	229	208	123	310
Total Gross Profit	561	664	793	1,159
Total Revenue	2,422	3,111	4,090	5,289
Operating Revenue	2,422	3,111	4,090	5,289
Total Cost of Revenue	1,861	2,448	3,297	4,130
Operating Cost of Revenue	1,861	2,448	3,297	4,130
Total Operating Expenses	331	456	670	850
Selling, General & Admin Expense	149	214	344	415
Depreciation Expense	22	26	41	56
Other Operating Expenses / (Income)	160	217	285	379
Total Other Income / (Expense), net	-22	-50	-22	-25
Interest Expense	26	50	44	28
Other Income / (Expense), net	3.22	-0.54	23	3.22
Income Tax Expense	57	44	46	93
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.01	-0.42	-0.08
Basic Earnings per Share	$1.17	$0.88	$0.38	$1.23
Weighted Average Basic Shares Outstanding	128.72M	128.72M	146.66M	156.18M
Diluted Earnings per Share	$1.17	$0.88	$0.38	$1.22
Weighted Average Diluted Shares Outstanding	128.72M	128.72M	148.57M	156.70M
Weighted Average Basic & Diluted Shares Outstanding	-	-	-	157.17M

This table shows PACS Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	21	20	34	35	-32	16	37	28	51	52	60
Consolidated Net Income / (Loss)	21	20	34	35	-32	16	36	28	51	52	60
Net Income / (Loss) Continuing Operations	21	20	34	35	-32	16	36	28	51	52	60
Total Pre-Tax Income	32	27	49	58	-51	34	61	43	79	76	87
Total Operating Income	50	36	63	65	-37	23	72	48	80	86	95
Total Gross Profit	170	151	174	184	174	177	259	253	288	298	319
Total Revenue	761	789	853	920	936	1,026	1,208	1,277	1,309	1,345	1,358
Operating Revenue	761	789	853	920	936	1,026	1,208	1,277	1,309	1,345	1,358
Total Cost of Revenue	591	638	680	736	762	850	949	1,024	1,021	1,046	1,039
Operating Cost of Revenue	591	638	680	736	762	850	949	1,024	1,021	1,046	1,039
Total Operating Expenses	120	114	111	119	211	154	187	205	208	212	225
Selling, General & Admin Expense	63	50	42	47	137	71	90	99	100	103	113
Depreciation Expense	6.16	6.36	7.28	8.12	9.25	11	13	13	13	14	15
Other Operating Expenses / (Income)	51	58	62	64	65	73	84	94	94	95	96
Total Other Income / (Expense), net	-18	-9.01	-13	-7.61	-14	11	-11	-5.41	-1.89	-9.97	-7.88
Interest Expense	15	10	14	16	9.92	9.03	9.30	6.90	4.35	8.53	8.58
Other Income / (Expense), net	-2.64	1.21	0.46	8.49	-3.91	20	-1.48	1.49	2.47	-1.44	0.70
Income Tax Expense	10	7.47	15	23	-19	17	25	14	28	24	27
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.00	0.00	0.00	0.59	-1.01	-0.09	0.00	-0.08	0.08
Basic Earnings per Share	$0.16	$0.15	$0.28	$0.27	($0.21)	$0.10	$0.22	$0.18	$0.33	$0.33	$0.39
Weighted Average Basic Shares Outstanding	128.72M	128.72M	128.72M	128.72M	149.46M	153.12M	146.66M	155.18M	156.34M	156.58M	156.18M
Diluted Earnings per Share	$0.16	$0.15	$0.28	$0.27	($0.21)	$0.10	$0.22	$0.17	$0.31	$0.32	$0.42
Weighted Average Diluted Shares Outstanding	128.72M	128.72M	128.72M	128.72M	149.46M	158.45M	148.57M	166.42M	165.47M	164.71M	156.70M
Weighted Average Basic & Diluted Shares Outstanding	-	-	0.00	24.64M	152.40M	-	0.00	-	-	156.62M	157.17M

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	30	20	42	71
Net Cash From Operating Activities	93	64	367	404
Net Cash From Continuing Operating Activities	93	64	367	404
Net Income / (Loss) Continuing Operations	150	113	55	191
Consolidated Net Income / (Loss)	150	113	55	191
Depreciation Expense	22	26	41	56
Amortization Expense	1.21	6.07	3.12	3.15
Non-Cash Adjustments To Reconcile Net Income	15	21	133	97
Changes in Operating Assets and Liabilities, net	-96	-102	135	57
Net Cash From Investing Activities	-75	-173	-443	-264
Net Cash From Continuing Investing Activities	-75	-173	-443	-264
Purchase of Property, Plant & Equipment	-78	-173	-350	-249
Acquisitions	0.00	-2.60	-33	0.00
Purchase of Investments	0.00	0.00	-91	-21
Sale of Property, Plant & Equipment	0.01	0.75	1.50	0.75
Sale and/or Maturity of Investments	0.00	0.00	26	0.00
Other Investing Activities, net	-	1.86	3.52	5.59
Net Cash From Financing Activities	12	130	117	-69
Net Cash From Continuing Financing Activities	12	130	117	-69
Repayment of Debt	-173	-1,058	-1,073	-60
Payment of Dividends	-60	-80	-34	-0.38
Issuance of Debt	242	1,267	748	0.00
Issuance of Common Equity	3.25	0.59	510	0.00
Other Financing Activities, net	0.00	0.00	-34	-8.40
Cash Interest Paid	26	51	48	41
Cash Income Taxes Paid	43	60	108	84

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q4 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	12/31/2025
Net Change in Cash & Equivalents	37	-54	9.63	29	-25	-15	-16	99	130	-127
Net Cash From Operating Activities	79	-21	15	-9.70	59	35	209	65	150	-3.39
Net Cash From Continuing Operating Activities	79	-21	15	-9.70	59	35	209	65	150	-3.39
Net Income / (Loss) Continuing Operations	38	21	20	34	35	-11	-19	36	28	60
Consolidated Net Income / (Loss)	38	21	20	34	35	-11	-19	36	28	60
Depreciation Expense	5.83	6.16	6.36	7.28	8.12	8.78	11	13	13	15
Amortization Expense	0.62	3.66	0.55	1.24	0.78	0.78	0.78	0.78	0.79	0.79
Non-Cash Adjustments To Reconcile Net Income	3.98	4.31	6.08	6.74	6.86	102	27	26	23	26
Changes in Operating Assets and Liabilities, net	31	-56	-18	-59	8.18	-65	189	-11	85	-106
Net Cash From Investing Activities	-58	-9.71	-46	-60	-119	-121	-99	-104	-16	-118
Net Cash From Continuing Investing Activities	-58	-9.71	-46	-60	-119	-121	-99	-104	-16	-118
Purchase of Property, Plant & Equipment	-58	-11	-46	-58	-89	-111	-66	-83	-18	-114
Purchase of Investments	0.00	-	-	-	-25	-10	-10	-46	0.00	-6.05
Sale of Property, Plant & Equipment	-	-	-	-	-	-	1.50	-	-	0.75
Other Investing Activities, net	0.47	0.47	0.45	0.47	-	0.52	-	-	1.30	1.42
Net Cash From Financing Activities	15	-24	40	98	34	71	-126	139	-4.07	-5.47
Net Cash From Continuing Financing Activities	15	-24	40	98	34	71	-126	139	-4.07	-5.47
Repayment of Debt	-44	-415	-100	-498	-105	-465	-366	-138	-4.07	-5.47
Payment of Dividends	-19	-25	-25	-11	-17	-16	-	-	0.00	0.00
Cash Interest Paid	9.93	18	7.39	15	16	9.91	14	8.90	8.09	12
Cash Income Taxes Paid	0.00	17	35	8.17	0.00	43	34	30	0.36	3.00

This table presents PACS Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	3,513	5,243	5,584
Total Current Assets	722	938	1,070
Cash & Equivalents	73	158	197
Accounts Receivable	600	717	702
Prepaid Expenses	49	64	171
Plant, Property, & Equipment, net	578	991	1,201
Total Noncurrent Assets	2,213	3,314	3,313
Goodwill	65	67	68
Other Noncurrent Operating Assets	2,148	3,247	3,245
Total Liabilities & Shareholders' Equity	3,513	5,243	5,584
Total Liabilities	3,411	4,527	4,632
Total Current Liabilities	457	978	1,001
Short-Term Debt	17	157	4.46
Accounts Payable	141	175	192
Accrued Expenses	70	142	154
Current Employee Benefit Liabilities	92	146	188
Other Current Liabilities	137	358	463
Total Noncurrent Liabilities	2,954	3,549	3,630
Long-Term Debt	716	251	345
Asset Retirement Reserve & Litigation Obligation	146	165	193
Other Noncurrent Operating Liabilities	2,092	3,133	3,093
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	102	716	952
Total Preferred & Common Equity	96	710	947
Total Common Equity	96	710	947
Common Stock	0.13	592	637
Retained Earnings	96	118	310
Noncontrolling Interest	5.60	6.14	5.68

This table presents PACS Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	3,861	3,933	4,517	5,494	5,502	5,627
Total Current Assets	821	764	735	1,081	1,077	1,127
Cash & Equivalents	81	73	50	288	294	356
Accounts Receivable	678	631	624	742	690	695
Prepaid Expenses	62	60	61	52	93	76
Plant, Property, & Equipment, net	667	857	925	999	1,032	0.00
Total Noncurrent Assets	2,373	2,312	2,857	3,414	3,392	4,500
Goodwill	65	65	65	67	67	68
Other Noncurrent Operating Assets	2,308	2,247	2,792	3,347	3,325	4,432
Total Liabilities & Shareholders' Equity	3,861	3,933	4,517	5,494	5,502	5,627
Total Liabilities	3,741	3,390	3,850	4,738	4,690	4,750
Total Current Liabilities	535	488	682	1,107	1,167	1,198
Short-Term Debt	17	16	16	155	152	107
Accounts Payable	157	126	155	199	172	205
Accrued Expenses	71	75	107	164	248	179
Current Employee Benefit Liabilities	144	99	155	210	193	253
Other Current Liabilities	147	172	249	379	402	453
Total Noncurrent Liabilities	2,662	2,647	3,168	3,631	3,522	3,552
Long-Term Debt	231	227	254	249	247	246
Asset Retirement Reserve & Litigation Obligation	155	172	188	187	208	177
Other Noncurrent Operating Liabilities	2,276	2,248	2,726	3,195	3,068	3,129
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	119	543	667	756	813	877
Total Preferred & Common Equity	114	537	660	750	807	871
Total Common Equity	113	537	660	750	807	871
Common Stock	0.13	472	579	604	609	621
Retained Earnings	113	65	81	147	197	250
Noncontrolling Interest	5.60	6.11	6.70	6.05	5.83	5.59

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	28.47%	31.44%	29.32%
EBITDA Growth	0.00%	-6.70%	-20.56%	95.78%
EBIT Growth	0.00%	-10.90%	-29.60%	114.41%
NOPAT Growth	0.00%	-10.58%	-55.01%	210.69%
Net Income Growth	0.00%	-24.99%	-50.97%	245.95%
EPS Growth	0.00%	-24.79%	-56.82%	221.05%
Operating Cash Flow Growth	0.00%	-31.22%	476.70%	10.04%
Free Cash Flow Firm Growth	0.00%	0.00%	77.45%	150.41%
Invested Capital Growth	0.00%	0.00%	26.95%	14.38%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	23.15%	21.33%	19.38%	21.92%
EBITDA Margin	10.57%	7.68%	4.64%	7.03%
Operating Margin	9.47%	6.68%	3.01%	5.85%
EBIT Margin	9.60%	6.66%	3.57%	5.91%
Profit (Net Income) Margin	6.21%	3.63%	1.35%	3.62%
Tax Burden Percent	72.69%	71.75%	54.50%	67.31%
Interest Burden Percent	89.02%	75.91%	69.61%	90.93%
Effective Tax Rate	27.31%	28.25%	45.50%	32.69%
Return on Invested Capital (ROIC)	0.00%	39.19%	7.77%	20.13%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	28.20%	5.19%	11.72%
Return on Net Nonoperating Assets (RNNOA)	0.00%	182.74%	5.77%	2.83%
Return on Equity (ROE)	0.00%	221.93%	13.54%	22.96%
Cash Return on Invested Capital (CROIC)	0.00%	-160.81%	-15.98%	6.72%
Operating Return on Assets (OROA)	0.00%	5.90%	3.33%	5.78%
Return on Assets (ROA)	0.00%	3.21%	1.26%	3.54%
Return on Common Equity (ROCE)	0.00%	209.72%	13.35%	22.79%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	167	149	67	208
NOPAT Margin	6.88%	4.79%	1.64%	3.94%
Net Nonoperating Expense Percent (NNEP)	0.00%	10.99%	2.58%	8.41%
Return On Investment Capital (ROIC_SIMPLE)	-	17.87%	5.97%	16.01%
Cost of Revenue to Revenue	76.85%	78.67%	80.62%	78.08%
SG&A Expenses to Revenue	6.15%	6.87%	8.41%	7.85%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.68%	14.66%	16.37%	16.06%
Earnings before Interest and Taxes (EBIT)	233	207	146	313
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	256	239	190	372
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	4.68	2.82	6.35
Price to Tangible Book Value (P/TBV)	0.00	14.59	3.11	6.84
Price to Revenue (P/Rev)	0.19	0.14	0.49	1.14
Price to Earnings (P/E)	2.99	3.99	35.83	31.39
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	33.44%	25.08%	2.79%	3.19%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.47	2.33	5.59
Enterprise Value to Revenue (EV/Rev)	0.00	0.36	0.55	1.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	4.67	11.88	16.60
Enterprise Value to EBIT (EV/EBIT)	0.00	5.38	15.45	19.73
Enterprise Value to NOPAT (EV/NOPAT)	0.00	7.48	33.61	29.61
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	17.50	6.14	15.26
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	88.73
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	7.20	0.57	0.37
Long-Term Debt to Equity	0.00	7.04	0.35	0.36
Financial Leverage	0.00	6.48	1.11	0.24
Leverage Ratio	0.00	34.53	10.71	6.49
Compound Leverage Factor	0.00	26.21	7.46	5.90
Debt to Total Capital	0.00%	87.81%	36.30%	26.83%
Short-Term Debt to Total Capital	0.00%	2.02%	13.96%	0.34%
Long-Term Debt to Total Capital	0.00%	85.79%	22.34%	26.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.67%	0.55%	0.44%
Common Equity to Total Capital	0.00%	11.52%	63.15%	72.73%
Debt to EBITDA	0.00	3.07	2.15	0.94
Net Debt to EBITDA	0.00	2.76	1.32	0.41
Long-Term Debt to EBITDA	0.00	3.00	1.32	0.93
Debt to NOPAT	0.00	4.91	6.08	1.68
Net Debt to NOPAT	0.00	4.42	3.73	0.73
Long-Term Debt to NOPAT	0.00	4.80	3.74	1.65
Altman Z-Score	0.00	1.29	1.16	2.00
Noncontrolling Interest Sharing Ratio	0.00%	5.51%	1.44%	0.71%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	1.58	0.96	1.07
Quick Ratio	0.00	1.47	0.89	0.90
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-612	-138	70
Operating Cash Flow to CapEx	118.39%	37.02%	105.46%	162.73%
Free Cash Flow to Firm to Interest Expense	0.00	-12.25	-3.11	2.45
Operating Cash Flow to Interest Expense	3.63	1.28	8.28	14.25
Operating Cash Flow Less CapEx to Interest Expense	0.56	-2.17	0.43	5.49
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.89	0.93	0.98
Accounts Receivable Turnover	0.00	5.19	6.21	7.46
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	5.39	0.00	4.83
Accounts Payable Turnover	0.00	17.37	20.87	22.49
Days Sales Outstanding (DSO)	0.00	70.39	58.75	48.95
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	21.02	17.49	16.23
Cash Conversion Cycle (CCC)	0.00	49.37	41.26	32.72
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	761	966	1,105
Invested Capital Turnover	0.00	8.18	4.74	5.11
Increase / (Decrease) in Invested Capital	0.00	761	205	139
Enterprise Value (EV)	0.00	1,115	2,254	6,170
Market Capitalization	450	450	1,998	6,012
Book Value per Share	$0.00	$0.75	$4.66	$6.05
Tangible Book Value per Share	$0.00	$0.24	$4.22	$5.61
Total Capital	0.00	834	1,124	1,302
Total Debt	0.00	733	408	349
Total Long-Term Debt	0.00	716	251	345
Net Debt	0.00	659	250	152
Capital Expenditures (CapEx)	78	172	348	248
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	209	-41	-124
Debt-free Net Working Capital (DFNWC)	0.00	282	117	73
Net Working Capital (NWC)	0.00	265	-40	68
Net Nonoperating Expense (NNE)	16	36	12	17
Net Nonoperating Obligations (NNO)	0.00	659	250	152
Total Depreciation and Amortization (D&A)	24	32	44	59
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	6.71%	-1.00%	-2.35%
Debt-free Net Working Capital to Revenue	0.00%	9.06%	2.85%	1.38%
Net Working Capital to Revenue	0.00%	8.52%	-0.98%	1.29%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.38	$1.23
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	146.66M	156.18M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.38	$1.22
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	148.57M	156.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	157.17M
Normalized Net Operating Profit after Tax (NOPAT)	167	149	67	208
Normalized NOPAT Margin	6.88%	4.79%	1.64%	3.94%
Pre Tax Income Margin	8.55%	5.06%	2.48%	5.38%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	9.11	4.15	3.29	11.03
NOPAT to Interest Expense	6.53	2.99	1.51	7.35
EBIT Less CapEx to Interest Expense	6.04	0.70	-4.56	2.27
NOPAT Less CapEx to Interest Expense	3.47	-0.46	-6.34	-1.41
Payout Ratios	-	-	-	-
Dividend Payout Ratio	40.05%	71.22%	60.93%	0.20%
Augmented Payout Ratio	40.05%	71.22%	60.93%	0.20%

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	31.94%	29.08%	0.00%	0.00%	38.85%	39.92%	31.01%	12.43%
EBITDA Growth	0.00%	0.00%	0.00%	46.76%	-88.79%	0.00%	0.00%	-23.66%	411.75%	81.46%	32.49%
EBIT Growth	0.00%	0.00%	0.00%	48.06%	-106.81%	0.00%	0.00%	-32.74%	301.94%	98.72%	35.30%
NOPAT Growth	0.00%	0.00%	0.00%	18.45%	-98.51%	0.00%	0.00%	-18.87%	300.53%	434.98%	53.19%
Net Income Growth	0.00%	0.00%	0.00%	30.70%	-151.40%	0.00%	0.00%	-18.49%	259.89%	222.83%	65.19%
EPS Growth	0.00%	0.00%	0.00%	31.03%	-143.75%	0.00%	0.00%	-37.04%	247.62%	220.00%	90.91%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	-25.86%	265.16%	0.00%	0.00%	155.73%	0.00%	0.00%	-105.25%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	98.56%	110.24%	0.00%	54.67%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.22%	-5.12%	0.00%	14.38%
Revenue Q/Q Growth	7.37%	3.75%	8.11%	0.00%	5.04%	4.53%	17.69%	0.00%	0.00%	0.00%	1.00%
EBITDA Q/Q Growth	-14.29%	-21.50%	60.61%	0.00%	-93.45%	760.19%	53.98%	0.00%	0.00%	0.00%	12.42%
EBIT Q/Q Growth	-21.49%	-19.80%	67.48%	0.00%	-103.61%	1,435.99%	65.16%	0.00%	0.00%	0.00%	12.45%
NOPAT Q/Q Growth	-26.71%	-20.43%	63.76%	0.00%	-99.08%	2,125.42%	284.86%	0.00%	0.00%	0.00%	10.20%
Net Income Q/Q Growth	-43.56%	-6.09%	71.31%	0.00%	-122.20%	248.61%	123.26%	0.00%	0.00%	0.00%	14.25%
EPS Q/Q Growth	-44.83%	-6.25%	86.67%	0.00%	-118.42%	242.86%	120.00%	0.00%	0.00%	0.00%	31.25%
Operating Cash Flow Q/Q Growth	-126.58%	172.05%	-163.88%	0.00%	-40.78%	500.78%	-69.12%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-27.06%	100.00%	0.00%	0.00%	0.00%	0.00%	90.97%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	18.95%	-100.00%	0.00%	0.00%	0.00%	0.00%	26.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.33%	19.10%	20.34%	21.26%	22.38%	17.22%	21.40%	19.84%	22.02%	22.19%	23.51%
EBITDA Margin	7.46%	5.64%	8.38%	10.39%	0.65%	5.33%	6.97%	4.94%	7.34%	7.38%	8.21%
Operating Margin	6.51%	4.61%	7.33%	8.55%	0.07%	2.24%	5.96%	3.77%	6.15%	6.42%	6.97%
EBIT Margin	6.17%	4.77%	7.38%	9.46%	-0.33%	4.16%	5.84%	3.89%	6.34%	6.31%	7.02%
Profit (Net Income) Margin	2.79%	2.53%	4.00%	5.26%	-1.11%	1.58%	3.00%	2.22%	3.89%	3.89%	4.40%
Tax Burden Percent	67.17%	72.74%	69.34%	67.26%	88.10%	48.16%	59.14%	66.42%	64.83%	68.59%	68.87%
Interest Burden Percent	67.36%	72.84%	78.16%	82.60%	387.54%	78.85%	86.81%	86.09%	94.75%	89.95%	91.01%
Effective Tax Rate	32.83%	27.26%	30.66%	32.74%	0.00%	51.84%	40.86%	33.58%	35.17%	31.41%	31.13%
Return on Invested Capital (ROIC)	0.00%	0.00%	20.78%	0.00%	0.00%	0.00%	14.92%	0.00%	0.00%	0.00%	24.53%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	19.38%	0.00%	0.00%	0.00%	12.37%	0.00%	0.00%	0.00%	21.84%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	125.60%	0.00%	0.00%	0.00%	4.33%	0.00%	0.00%	0.00%	5.27%
Return on Equity (ROE)	0.00%	0.00%	146.38%	0.00%	0.00%	0.00%	19.25%	0.00%	0.00%	0.00%	29.80%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-80.41%	0.00%	0.00%	0.00%	-14.28%	-5.09%	0.00%	0.00%	6.72%
Operating Return on Assets (OROA)	0.00%	0.00%	6.54%	0.00%	0.00%	0.00%	5.45%	0.00%	0.00%	0.00%	6.86%
Return on Assets (ROA)	0.00%	0.00%	3.54%	0.00%	0.00%	0.00%	2.80%	0.00%	0.00%	0.00%	4.30%
Return on Common Equity (ROCE)	0.00%	0.00%	138.32%	0.00%	0.00%	0.00%	18.97%	0.00%	0.00%	0.00%	29.59%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	33	26	43	54	0.50	11	43	32	52	59	65
NOPAT Margin	4.37%	3.36%	5.08%	5.75%	0.05%	1.08%	3.52%	2.50%	3.99%	4.40%	4.80%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	1.40%	1.32%	5.46%	0.00%	2.55%	0.87%	0.46%	-596.10%	2.70%
Return On Investment Capital (ROIC_SIMPLE)	-	-	5.20%	-	-	-	3.79%	2.76%	4.31%	4.81%	5.01%
Cost of Revenue to Revenue	77.67%	80.91%	79.66%	78.74%	77.62%	82.78%	78.60%	80.16%	77.98%	77.81%	76.49%
SG&A Expenses to Revenue	8.24%	6.28%	4.92%	5.02%	14.71%	6.88%	7.42%	7.73%	7.66%	7.63%	8.36%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.82%	14.48%	13.01%	12.71%	22.30%	14.98%	15.44%	16.07%	15.88%	15.77%	16.53%
Earnings before Interest and Taxes (EBIT)	47	38	63	88	-3.20	43	70	50	83	85	95
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	57	45	72	97	6.36	55	84	63	96	99	112
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	4.68	3.52	1.27	0.00	2.82	2.28	2.44	2.40	6.35
Price to Tangible Book Value (P/TBV)	0.00	0.00	14.59	7.18	1.43	0.00	3.11	2.51	2.66	2.60	6.84
Price to Revenue (P/Rev)	0.00	0.00	0.14	0.00	0.00	0.00	0.49	0.00	0.00	0.00	1.14
Price to Earnings (P/E)	0.00	0.00	3.99	0.00	0.00	0.00	35.83	0.00	0.00	0.00	31.39
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	25.08%	0.00%	0.00%	0.00%	2.79%	0.00%	0.00%	0.00%	3.19%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.47	1.38	1.16	0.00	2.33	2.10	2.27	2.40	5.59
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.36	0.00	0.00	0.00	0.55	0.00	0.00	0.00	1.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	4.67	0.00	0.00	0.00	11.88	0.00	0.00	0.00	16.60
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	5.38	0.00	0.00	0.00	15.45	0.00	0.00	0.00	19.73
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	7.48	0.00	0.00	0.00	33.61	0.00	0.00	0.00	29.61
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	17.50	0.00	0.00	0.00	6.14	0.00	0.00	0.00	15.26
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	88.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	7.20	5.87	0.85	0.00	0.57	0.53	0.49	0.40	0.37
Long-Term Debt to Equity	0.00	0.00	7.04	5.75	0.82	0.00	0.35	0.33	0.30	0.28	0.36
Financial Leverage	0.00	0.00	6.48	5.27	0.72	0.00	0.35	0.94	0.39	0.00	0.24
Leverage Ratio	0.00	0.00	34.53	28.94	6.74	0.00	10.71	10.68	6.96	6.42	6.49
Compound Leverage Factor	0.00	0.00	26.99	23.90	26.11	0.00	9.30	9.20	6.59	5.77	5.91
Debt to Total Capital	0.00%	0.00%	87.81%	85.45%	45.91%	0.00%	36.30%	34.82%	32.94%	28.72%	26.83%
Short-Term Debt to Total Capital	0.00%	0.00%	2.02%	1.83%	1.47%	0.00%	13.96%	13.35%	12.56%	8.74%	0.34%
Long-Term Debt to Total Capital	0.00%	0.00%	85.79%	83.62%	44.44%	0.00%	22.34%	21.47%	20.38%	19.99%	26.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.67%	0.61%	0.57%	0.00%	0.55%	0.52%	0.48%	0.45%	0.44%
Common Equity to Total Capital	0.00%	0.00%	11.52%	13.94%	53.52%	0.00%	63.15%	64.66%	66.58%	70.82%	72.73%
Debt to EBITDA	0.00	0.00	3.07	0.00	0.00	0.00	2.15	0.00	0.00	0.00	0.94
Net Debt to EBITDA	0.00	0.00	2.76	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.41
Long-Term Debt to EBITDA	0.00	0.00	3.00	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.93
Debt to NOPAT	0.00	0.00	4.91	0.00	0.00	0.00	6.08	0.00	0.00	0.00	1.68
Net Debt to NOPAT	0.00	0.00	4.42	0.00	0.00	0.00	3.73	0.00	0.00	0.00	0.73
Long-Term Debt to NOPAT	0.00	0.00	4.80	0.00	0.00	0.00	3.74	0.00	0.00	0.00	1.65
Altman Z-Score	0.00	0.00	1.15	0.29	0.27	0.00	1.11	0.28	0.00	0.00	1.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	5.51%	4.19%	1.06%	0.00%	1.44%	1.35%	0.00%	0.00%	0.71%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	1.58	1.56	1.71	0.00	0.96	0.98	0.92	0.94	1.07
Quick Ratio	0.00	0.00	1.47	1.45	1.57	0.00	0.89	0.93	0.84	0.88	0.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	-783	-995	0.00	0.00	-11	102	-815	-74
Operating Cash Flow to CapEx	-192.86%	32.99%	-16.78%	65.86%	31.23%	324.81%	77.66%	848.02%	0.00%	0.00%	-2.99%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-50.89	-108.33	0.00	0.00	-1.64	23.36	-95.61	-8.59
Operating Cash Flow to Interest Expense	-1.38	1.49	-0.71	3.82	3.79	23.16	6.94	21.76	0.00	0.00	-0.40
Operating Cash Flow Less CapEx to Interest Expense	-2.09	-3.02	-4.91	-1.98	-8.35	16.03	-2.00	19.20	0.00	0.00	-13.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.89	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.98
Accounts Receivable Turnover	0.00	0.00	5.19	0.00	0.00	0.00	6.21	0.00	0.00	0.00	7.46
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	5.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.83
Accounts Payable Turnover	0.00	0.00	17.37	0.00	0.00	0.00	20.87	0.00	0.00	0.00	22.49
Days Sales Outstanding (DSO)	0.00	0.00	70.39	0.00	0.00	0.00	58.75	0.00	0.00	0.00	48.95
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	21.02	0.00	0.00	0.00	17.49	0.00	0.00	0.00	16.23
Cash Conversion Cycle (CCC)	0.00	0.00	49.37	0.00	0.00	0.00	41.26	0.00	0.00	0.00	32.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.00	761	837	996	0.00	966	873	918	875	1,105
Invested Capital Turnover	0.00	0.00	4.09	0.00	0.00	0.00	4.23	0.00	0.00	0.00	5.11
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	837	996	0.00	0.00	43	-50	875	139
Enterprise Value (EV)	0.00	0.00	1,115	1,159	1,151	0.00	2,254	1,836	2,080	2,096	6,170
Market Capitalization	450	450	450	450	727	6,091	1,998	1,713	1,969	2,092	6,012
Book Value per Share	$0.00	$0.00	$0.75	$0.99	$3.83	$0.00	$4.66	$4.92	$5.29	$5.72	$6.05
Tangible Book Value per Share	$0.00	$0.00	$0.24	$0.49	$3.39	$0.00	$4.22	$4.48	$4.85	$5.27	$5.61
Total Capital	0.00	0.00	834	918	1,069	0.00	1,124	1,160	1,212	1,230	1,302
Total Debt	0.00	0.00	733	785	491	0.00	408	404	399	353	349
Total Long-Term Debt	0.00	0.00	716	768	475	0.00	251	249	247	246	345
Net Debt	0.00	0.00	659	703	417	0.00	250	117	105	-2.30	152
Capital Expenditures (CapEx)	11	46	58	89	111	64	83	18	0.00	0.00	114
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	209	236	275	0.00	-41	-159	-232	-319	-124
Debt-free Net Working Capital (DFNWC)	0.00	0.00	282	317	348	0.00	117	129	62	37	73
Net Working Capital (NWC)	0.00	0.00	265	300	333	0.00	-40	-26	-90	-71	68
Net Nonoperating Expense (NNE)	12	6.55	9.22	4.64	11	-5.15	6.38	3.59	1.22	6.84	5.42
Net Nonoperating Obligations (NNO)	0.00	0.00	659	703	417	0.00	250	117	105	-2.30	152
Total Depreciation and Amortization (D&A)	9.82	6.91	8.52	8.68	9.55	12	14	13	13	14	16
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	6.71%	0.00%	0.00%	0.00%	-1.00%	0.00%	0.00%	0.00%	-2.35%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	9.06%	0.00%	0.00%	0.00%	2.85%	0.00%	0.00%	0.00%	1.38%
Net Working Capital to Revenue	0.00%	0.00%	8.52%	0.00%	0.00%	0.00%	-0.98%	0.00%	0.00%	0.00%	1.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.28	$0.38	($0.07)	$0.00	$0.22	$0.18	$0.33	$0.33	$0.39
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	128.72M	128.72M	149.46M	0.00	146.66M	155.18M	156.34M	156.58M	156.18M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.28	$0.38	($0.07)	$0.00	$0.22	$0.17	$0.31	$0.32	$0.42
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	128.72M	128.72M	149.46M	0.00	148.57M	166.42M	165.47M	164.71M	156.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	24.64M	152.40M	0.00	0.00	0.00	0.00	156.62M	157.17M
Normalized Net Operating Profit after Tax (NOPAT)	33	26	43	54	0.50	16	43	32	52	59	65
Normalized NOPAT Margin	4.37%	3.36%	5.08%	5.75%	0.05%	1.57%	3.52%	2.50%	3.99%	4.40%	4.80%
Pre Tax Income Margin	4.15%	3.47%	5.77%	7.82%	-1.26%	3.28%	5.07%	3.35%	6.00%	5.67%	6.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.06	3.68	4.58	5.75	-0.35	4.73	7.58	7.19	19.06	9.95	11.12
NOPAT to Interest Expense	2.17	2.59	3.15	3.49	0.05	1.23	4.58	4.63	11.99	6.94	7.60
EBIT Less CapEx to Interest Expense	2.35	-0.82	0.38	-0.05	-12.48	-2.40	-1.36	4.62	0.00	0.00	-2.11
NOPAT Less CapEx to Interest Expense	1.46	-1.91	-1.05	-2.31	-12.08	-5.91	-4.37	2.06	0.00	0.00	-5.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	71.22%	0.00%	0.00%	0.00%	60.93%	0.00%	0.00%	0.00%	0.20%
Augmented Payout Ratio	0.00%	0.00%	71.22%	0.00%	0.00%	0.00%	60.93%	0.00%	0.00%	0.00%	0.20%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused trend analysis of PACS Group (NYSE:PACS) using the latest quarterly data across 2021–2025, with a focus on the four most recent years of statements (Q1–Q4 2025, plus representative prior quarters for context). The highlights below point to where the company has shown strength, as well as where it faces ongoing leverage and cash-flow challenges.

Revenue momentum: Operating revenue increased across 2025, finishing Q4 2025 at 1,357,979,000 USD, up from 1,207,888,000 USD in Q4 2024 (and higher than each prior quarter in 2025: Q1 1.277B, Q2 1.309B, Q3 1.344B).
Gross margin improvement: Gross profit for Q4 2025 was 319,215,000 USD on 1,357,979,000 USD of revenue, about a 23.5% gross margin, up from roughly 21.4% in Q4 2024 (258,535,000 USD gross profit on 1,207,888,000 USD revenue).
Earnings per share and net income to shareholders improving: Q4 2025 net income attributable to common shareholders was 59,702,000 USD, with diluted earnings per share of 0.42 USD and basic of 0.39 USD, up from Q4 2024 levels (net income to common around 37,201,000 USD; diluted EPS ~0.32 USD; basic ~0.22 USD).
Operating income strengthened: Q4 2025 total operating income reached 94,687,000 USD, up from 61,198,000 USD in Q4 2024, indicating improved operating profitability despite higher costs.
Debt and equity structure: Total liabilities remained high relative to equity in 2025 (Total Liabilities around 4.75B USD vs. Total Equity & Noncontrolling Interests around 0.88B USD in Q3 2025), signaling a levered balance sheet but a relatively modest equity base to absorb shocks.
Debt load and stability: Long-term debt hovered around 246M USD across 2025 (e.g., 246.99M in Q2 2025 and 245.90M in Q3 2025), showing little year-over-year change in base debt level.
Liquidity snapshot: Cash & equivalents were about 355.7M USD at the Q3 2025 balance sheet, with cash balances fluctuating across quarters; this provides a moderate liquidity cushion but must be watched given cash-flow dynamics.
Near-term cash flow pressure: For Q4 2025, cash flow from continuing operating activities was negative (-3,390,000 USD), even as earnings rose, suggesting working-capital and non-cash adjustments are pressure points.
Cash burn in the quarter: Net change in cash and equivalents for Q4 2025 was -127,005,000 USD, indicating a meaningful quarterly cash outflow notwithstanding higher profits.
Financing/capital actions: Net cash from financing activities in Q4 2025 was negative (-5,469,000 USD), implying limited external funding activity or net debt reduction during the quarter.
Noncurrent liabilities and related obligations: Other noncurrent liabilities were substantial (about 3.13B USD in the latest period), contributing to a large noncurrent-liability base alongside total noncurrent liabilities (~3.55B USD). This underscores significant long-term obligations relative to current equity, heightening balance-sheet risk.

05/11/26 03:28 PM ETAI Generated. May Contain Errors.

PACS Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PACS Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

PACS Group's net income appears to be on an upward trend, with a most recent value of $191.46 million in 2025, rising from $150.50 million in 2022. The previous period was $55.34 million in 2024. See PACS Group's forecast for analyst expectations on what's next for the company.

PACS Group's total operating income in 2025 was $309.60 million, based on the following breakdown:

Total Gross Profit: $1.16 billion
Total Operating Expenses: $849.64 million

Over the last 3 years, PACS Group's total revenue changed from $2.42 billion in 2022 to $5.29 billion in 2025, a change of 118.4%.

PACS Group's total liabilities were at $4.63 billion at the end of 2025, a 2.3% increase from 2024, and a 35.8% increase since 2023.

In the past 2 years, PACS Group's cash and equivalents has ranged from $73.42 million in 2023 to $197.02 million in 2025, and is currently $197.02 million as of their latest financial filing in 2025.

Over the last 3 years, PACS Group's book value per share changed from 0.00 in 2022 to 6.05 in 2025, a change of 604.5%.

Related Companies

Financial statements for NYSE:PACS last updated on 3/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PACS Group (PACS) Financials

Financials Breakdown Chart

Key Financial Trends

PACS Group Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PACS Group (PACS) Financials

Annual Income Statements for PACS Group

Quarterly Income Statements for PACS Group

Annual Cash Flow Statements for PACS Group

Quarterly Cash Flow Statements for PACS Group

Annual Balance Sheets for PACS Group

Quarterly Balance Sheets for PACS Group

Annual Metrics And Ratios for PACS Group

Quarterly Metrics And Ratios for PACS Group

Financials Breakdown Chart

Key Financial Trends

PACS Group Financials - Frequently Asked Questions

When does PACS Group's fiscal year end?

How has PACS Group's net income changed over the last 3 years?

What is PACS Group's operating income?

How has PACS Group's revenue changed over the last 3 years?

How much debt does PACS Group have?

How much cash does PACS Group have?

How has PACS Group's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools